The Regulatory Times March 2018
Rich Jinks2018-08-13T15:43:27+00:00Your monthly compilation of regulatory news from around the globe. Follow the link to read March's edition from Kinapse.
Kinapse at Interphex 2018
Rich Jinks2018-03-28T13:04:47+00:00From April 17th-19th, Kinapse will be represented at the 2018 Interphex conference in New York. Come find us at Booth 1338.
Why US organisations need to prepare for an equivalent to EMA policy 0070
Rich Jinks2018-08-13T15:43:30+00:00A recently announced FDA pilot program suggests that the agency is taking steps towards implementing an equivalent to the EMA's policy 0070. US-based organisations should act now to prepare.
Kinapse signs the Armed Forces Covenant
Rich Jinks2018-07-17T16:03:36+00:00On 20th March 2018, Kinapse was proud to sign the Armed Forces Covenant. We were honoured to welcome Major General Chris Tickell CBE to our Wimbledon offices to celebrate with us and to countersign our Covenant on behalf of The Ministry of Defence.
Artificial intelligence in the Life Sciences industry
Rich Jinks2018-08-13T15:43:46+00:00With the Life Sciences industry playing catch-up on AI, how are industry leaders narrowing the gap? John Cogan, Head of innovation, shares his views.
A best practice approach for achieving EMA policy 0070 compliance
Emma Bulmer2018-08-13T15:43:40+00:00Want to learn the most efficient way to run a clinical trial anonymisation project? Read our step-by-step guide to achieving EMA policy 0070 compliance.
GDPR: What Life Sciences organisations need to do to comply
Emma Bulmer2018-08-13T15:43:53+00:00Is your Biopharmaceutical organisation ready for GDPR? Read on to learn what steps you need to take to ensure compliance with the new regulation.
